Search research articles
Contact Us
Filters
Showing results (61-70 of 106) with videos related to
Page
of 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
April 23, 2008
The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility
Jeroen J Lammerts van Bueren, Wim K Bleeker, Annika Brännström, et al.
Mabs
|
August 4, 2020
Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies
Mitchell Evers, Toine Ten Broeke, J H Marco Jansen, et al.
Cancer Research
|
July 3, 2008
Complement-dependent tumor cell lysis triggered by combinations of epidermal growth factor receptor antibodies
Michael Dechant, Wencke Weisner, Sven Berger, et al.
Bone Marrow Transplantation
|
July 11, 2021
Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMT
Frédéric Baron, Maud Ngoya, Myriam Labopin, et al.
Hemasphere
|
March 4, 2024
Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade
Denis M Schewe, Fotini Vogiatzi, Ira A Münnich, et al.
Frontiers in Immunology
|
February 23, 2026
Blinatumomab-driven T-cell activation in αβ and γδ T-cell subsets: insights from <i>in vitro</i> assays
Miriam Kelm, Nourhan Nasr, Sonja Bendig, et al.
Blood Advances
|
September 15, 2021
The selection of variable regions affects effector mechanisms of IgA antibodies against CD20
Mitchell Evers, Thies Rösner, Anna Dünkel, et al.
Molecular Cancer Therapeutics
|
March 3, 2019
Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies
Joseph Tintelnot, Natalie Baum, Christoph Schultheiß, et al.
Cancer Science
|
May 31, 2021
Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions
Niklas Baumann, Thies Rösner, J H Marco Jansen, et al.
Cancer Research
|
January 25, 2024
Human Tumor-Associated Macrophages and Neutrophils Regulate Antitumor Antibody Efficacy through Lethal and Sublethal Trogocytosis
Sunil Singhal, Abhishek S Rao, Jason Stadanlick, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 106) with videos related to
Sort By:
Page
of 11
Proceedings of the National Academy of Sciences of the United States of America
|
April 23, 2008
The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility
Jeroen J Lammerts van Bueren, Wim K Bleeker, Annika Brännström, et al.
Mabs
|
August 4, 2020
Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies
Mitchell Evers, Toine Ten Broeke, J H Marco Jansen, et al.
Cancer Research
|
July 3, 2008
Complement-dependent tumor cell lysis triggered by combinations of epidermal growth factor receptor antibodies
Michael Dechant, Wencke Weisner, Sven Berger, et al.
Bone Marrow Transplantation
|
July 11, 2021
Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMT
Frédéric Baron, Maud Ngoya, Myriam Labopin, et al.
Hemasphere
|
March 4, 2024
Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade
Denis M Schewe, Fotini Vogiatzi, Ira A Münnich, et al.
Frontiers in Immunology
|
February 23, 2026
Blinatumomab-driven T-cell activation in αβ and γδ T-cell subsets: insights from <i>in vitro</i> assays
Miriam Kelm, Nourhan Nasr, Sonja Bendig, et al.
Blood Advances
|
September 15, 2021
The selection of variable regions affects effector mechanisms of IgA antibodies against CD20
Mitchell Evers, Thies Rösner, Anna Dünkel, et al.
Molecular Cancer Therapeutics
|
March 3, 2019
Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies
Joseph Tintelnot, Natalie Baum, Christoph Schultheiß, et al.
Cancer Science
|
May 31, 2021
Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions
Niklas Baumann, Thies Rösner, J H Marco Jansen, et al.
Cancer Research
|
January 25, 2024
Human Tumor-Associated Macrophages and Neutrophils Regulate Antitumor Antibody Efficacy through Lethal and Sublethal Trogocytosis
Sunil Singhal, Abhishek S Rao, Jason Stadanlick, et al.
Page
of 11